Abstract
Purpose
Prenatal DES exposure has been associated with increased risk of breast cancer, but the mechanisms are unknown. Larger bra cup size has also been associated with increased breast cancer risk, although not consistently. We investigated the relation of prenatal DES exposure to mammary gland mass, as estimated by bra cup size.
Methods
In 2006, 3,222 DES-exposed and 1,463 unexposed women reported their bra cup size, band size (chest circumference), and weight at age 20. Prevalence ratios (PR) were calculated for DES exposure in relation to large bra cup size, with control for year of birth and study cohort. Primary analyses were carried out among women who reported a chest circumference of no more than 32 inches because their cup size would be less influenced by fat mass.
Results
Within this group, DES-exposed women had an estimated 45 % increased prevalence (95 % CI 0.97–2.18) of large cup size (C or greater) relative to unexposed women. The PR was further increased among women in this group who had a body mass index of < 21 at age 20: PR = 1.83 (95 % CI 1.11–3.00). The PR for high-dose DES exposure relative to no exposure was 1.67, 95 % CI 1.02–2.73, whereas there was no association of bra cup size with low-dose exposure.
Conclusions
These results provide support for the hypothesis that in utero DES exposure may result in greater mammary gland mass. Taken together with previous research on bra size and breast cancer risk, these findings suggest a mechanism for a possible association of in utero DES exposure with increased risk of breast cancer.
References
Palmer JR, Wise LA, Hatch EE et al (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(8):1509–1514
Albanes D, Winick M (1988) Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 80(10):772–774
Kolonel LN, Nomura AM, Lee J et al (1986) Anthropometric indicators of breast cancer risk in postmenopausal women in Hawaii. Nutr Cancer 8(4):247–256
Scutt D, Manning JT, Whitehouse GH et al (1997) The relationship between breast asymmetry, breast size and the occurrence of breast cancer. Br J Radiol 70(838):1017–1021
Kato I, Beinart C, Bleich A et al (1995) A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 6(5):431–438
Wynder EL, Bross IJ, Hirayama T (1960) A study of the epidemiology of cancer of the breast. Cancer 13:559–601
Egan KM, Newcomb PA, Titus-Ernstoff L et al (1999) The relation of breast size to breast cancer risk in postmenopausal women (United States). Cancer Causes Control 10(2):115–118
Kusano AS, Trichopoulos D, Terry KL et al (2006) A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 118(8):2031–2034
Hsieh CC, Trichopoulos D (1991) Breast size, handedness and breast cancer risk. Eur J Cancer 27(2):131–135
Deapen DM, Pike MC, Casagrande JT et al (1986) The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg 77(3):361–368
Berkel H, Birdsell DC, Jenkins H (1992) Breast augmentation: a risk factor for breast cancer? N Engl J Med 326(25):1649–1653
Valaoras VG, MacMahon B, Trichopoulos D et al (1969) Lactation and reproductive histories of breast cancer patients in greater Athens, 1965–67. Int J Cancer 4(3):350–363
Hirohata T, Nomura AM, Kolonel LN (1977) Breast size and cancer. Br Med J 2(6087):641
Soini I (1977) Risk factors of breast cancer in Finland. Int J Epidemiol 6(4):365–373
Tavani A, Pregnolato A, La Vecchia C et al (1996) Breast size and breast cancer risk. Eur J Cancer Prev 5(5):337–342
Hatch EE, Palmer JR, Titus-Ernstoff L et al (1998) Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 280(7):630–634
Labarthe D, Adam E, Noller KL et al (1978) Design and preliminary observations of National cooperative diethylstilbestrol adenosis (DESAD) project. Obstet Gynecol 51(4):453–458
Bibbo M, Gill WB, Azizi F et al (1977) Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 49(1):1–8
Colton T, Greenberg ER, Noller K et al (1993) Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA 269(16):2096–2100
Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162(3):199–200
Ringberg A, Bageman E, Rose C et al (2006) Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer 119(9):2242–2243 author reply 4
Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16(9):1700–1712
Trichopoulos D, Lipman RD (1992) Mammary gland mass and breast cancer risk. Epidemiology 3(6):523–526
Trichopoulos D, Lagiou P, Adami HO (2005) Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 7(1):13–17
Hovey RC, Asai-Sato M, Warri A et al (2005) Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 72(2):423–435
Ceriani RL (1970) Fetal mammary gland differentiation in vitro in response to hormones. I. Morphological findings. Dev Biol 21(4):506–529
Turashvili G, Bouchal J, Burkadze G et al (2005) Mammary gland development and cancer. Cesk Patol 41(3):94–101
Eriksson N, Benton GM, Do CB et al (2012) Genetic variants associated with breast size also influence breast cancer risk. BMC Med Genet 13:53
Stacey SN, Sulem P, Zanon C et al (2010) Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 6(7):e1001029
Ghoussaini M, Fletcher O, Michailidou K et al (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44(3):312–318
Acknowledgments
This research was support by a contract from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. We thank the field center study managers, Diane Anderson, Elizabeth Barnard, Toni Oliver, Elaine Campbell, Polly Goralski, Kathleen Rowlings, Helen Bond, Ann Urbanovitch, and Kathyln Tucke. We also appreciate the support of Cathy Ann Grundmayer, Shelley Niwa, and Bob Saal of Westat, Inc., for study-wide coordination efforts. Finally, we thank the DES-exposed and unexposed daughters for their longstanding participation in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Palmer, J.R., Boggs, D.A., Hatch, E.E. et al. Prenatal DES exposure in relation to breast size. Cancer Causes Control 24, 1757–1761 (2013). https://doi.org/10.1007/s10552-013-0248-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-013-0248-3